(Q39535191)

12 September 2017

title

Relationship between lunasin's sequence and its inhibitory activity of histones H3 and H4 acetylation (English)

1 reference

12 September 2017

author name string

Blanca Hernández-Ledesma

series ordinal

1

1 reference

12 September 2017

Chia-Chien Hsieh

series ordinal

2

1 reference

12 September 2017

Ben O de Lumen

series ordinal

3

1 reference

12 September 2017

publication date

25 May 2011

1 reference

Molecular Nutrition and Food Research

12 September 2017

published in

1 reference

12 September 2017

volume

55

1 reference

12 September 2017

issue

7

1 reference

12 September 2017

page(s)

989-998

1 reference

Chromatin-modifying proteins in cancer.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Epigenetics: a landscape takes shape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

The role of chromatin during transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

The language of covalent histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Small molecule modulators of histone acetyltransferase p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Lunasin, a novel seed peptide for cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Lunasin suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Soybean peptide lunasin suppresses in vitro and in vivo 7,12-dimethylbenz[a]anthracene-induced tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Lunasin, a novel seed peptide, sensitizes human breast cancer MDA-MB-231 cells to aspirin-arrested cell cycle and induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Cancer-preventive peptide lunasin from Solanum nigrum L. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinoblastoma protein (Rb).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Inhibition of core histone acetylation by the cancer preventive peptide lunasin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

A non-isotopic in vitro assay for histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Tumor suppressor pp32 represses cell growth through inhibition of transcription by blocking acetylation and phosphorylation of histone H3 and initiating its proapoptotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

The role of histone modifications and variants in regulating gene expression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Organization of chromatin in cancer cells: role of signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Histone deacetylation in epigenetics: an attractive target for anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Characterization of novel inhibitors of histone acetyltransferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Implications of small molecule activators and inhibitors of histone acetyltransferases in chromatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Global histone modification patterns predict risk of prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Global histone modifications predict prognosis of resected non small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Regulation of the mammalian cell cycle: a model of the G1-to-S transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

Mutations truncating the EP300 acetylase in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201000632

21 January 2018

Identifiers

DOI

10.1002/MNFR.201000632

1 reference

release_vkadzuvg4bhb5pse66slvpwr24

12 September 2017

Fatcat ID

0 references

1 reference